Table 2 Characteristics of the case series: IOP course and management
From: Brimonidine-associated uveitis – a descriptive case series
ID | Age | Type of glaucoma | Eyes affected | Management: (All stopped Brimonidine) | IOP R/L (mmHg) | IOP R/ L (mmHg) course and surgical management if needed at follow-up | Follow-up time |
|---|---|---|---|---|---|---|---|
1 | 80’s-90’s | NTG | Both | steroids (pred) | 20 15 | 14 15 | 84 mo. |
2 | 60’s-70’s | OHT | Both | steroids (dexa, flu) | 21 22 | 18 14 | 14 mo. |
3 | 80’s-90’s | NTG | Both | steroids (dexa) | 42 35 | 6 with Acet 6 with Acet | 1 mo. |
4 | 70’s-80’s | POAG | Both | steroids (dexa) | 35 41 | 34 - > TE –> 13 after 2x N 34 - > TE –> 7 | 28 mo. |
5 | 60’s-70’s | POAG | Left | steroids (dexa) | (13) 15 | (12–16) 12–16 | 2 mo. |
6 | 70’s-80’s | PXG | Both | – | 41 24 | 12 after TE - > 10 34 –> 34 | 1 mo. |
7 | 80’s-90’s | POAG | Left | steroids (dexa) | (13) 17 | (15 - > CPC - > 10) 24 - > CPC 10 | 1 mo. |
8 | 80’s-90’s | PXG (R); PXG - > rubeotic secondary glaucoma ^^ (L) | Both | – | 31 59 | 10–18 26–45 with Acet | 3 mo. |
9 | 80’s-90’s | PXG | Left | steroids (dexa) | (15) 22 | (22 - > 12) 31 –> CPC - > 16 | 9 mo. |
10 | 70’s-80’s | POAG - > rubeotic secondary glaucoma ^ (R); POAG (L) | Right | steroids (pred) | 24 (10) | 13 - > 45 - > 2x CPC - > 36 (10 - > 20 - > 19) | 7 mo. |
11 | 40’s-50’s | secondary glaucoma | Left | – | (18) 29 | (18 - > 10) CPC - > 23 - > 21 | 12 mo. |
12 | 70’s-80’s | POAG | Right | – | 28 (20) | 19–22 (6–16) | 1 mo. |
13 | 70’s-80’s | PXG | Both | – | 13 27 | CPC 16 16 (with Acet) | 0.5 mo. (lost to follow-up) |
14 | 70’s-80’s | PXG | Both | steroids (dexa) | 15 15 | (lost to follow-up) | |
15 | 80’s-90’s | PXG | Both | steroids (flu) | 30 17 | 30 - > TE - > 8 17 - > 17 | 1 mo. |
16 | 80’s-90’s | PXG | Both | steroids (dexa) | 18 15 | 5 9 | 1 mo. |